SCHEMBL25003377

SCHEMBL25003377

COC(=O)[C@H](CSSC[C@@H](NC(=O)OC(C)(C)C)C(=O)OC)NC(=O)OC(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
HTT P42858 1/20 0.55
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GSTP1 P09211 1/20 0.46
GSTM2 P28161 1/20 0.46
CTSK P43235 5/20 0.46
CTSS P25774 4/20 0.46
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
PPARG P37231 4/20 0.43
PPARA Q07869 4/20 0.43
ITGB1 P05556 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9679578 1.00 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL9679571 1.00 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL20531111 1.00 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL14227034 0.94 CYP1A2 (0.53) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL29740118 0.92 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL18167329 0.91 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL28777391 0.91 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL15608320 0.91 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL7539326 0.91 CYP1A2 (0.48) CYP1A2CYP2C9CYP2C19HTTNFKB1
SCHEMBL7539324 0.91 CYP1A2 (0.48) CYP1A2CYP2C9CYP2C19HTTNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043330-A1 Cystine Diamide Analogs For Cystinuria RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043330-A1 Cystine Diamide Analogs For Cystinuria CTH, CBS, SLC7A11 CYP1A2 4197/4885CYP2C9 3077/4885CYP2C19 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.